Bayer | BAYN - Current Liabilities


Bayer reported EUR32.27B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Air Liquide EUR 11.46B 2.7B Jun/2026
Akzo Nobel EUR 4.37B 56M Sep/2026
Alcon AG USD 3.17B 163M Jun/2026
Amarin USD 164.2M 15.45M Jun/2026
Arkema EUR 3.16B 1.01B Jun/2026
AstraZeneca USD 31.55B 1.02B Jun/2026
BASF EUR 20.91B 1.26B Jun/2026
Bayer EUR 32.27B 1.19B Jun/2026
Beiersdorf EUR 3.51B 261M Dec/2025
Corteva USD 10.79B 1.07B Jun/2026
Covestro EUR 3.87B 299M Dec/2025
Essilor EUR 12.64B 490M Jun/2026
Fresenius EUR 9.07B 468M Jun/2026
Fresenius Medical Care EUR 7.18B 448.03M Jun/2026
Genmab DKK 1.14B 38M Jun/2026
Givaudan CHF 2.35B 422M Dec/2025
GlaxoSmithKline GBP 21.53B 895M Jun/2026
GRIFOLS EUR 2.24B 112M Jun/2026
Henkel EUR 9.94B 1.53B Jun/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Johnson Matthey GBP 2.53B 211M Jun/2026
Linde USD 15.39B 193M Mar/2026
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 8.12B 1.22B Jun/2026
Novartis USD 31.75B 374M Jun/2026
Nutrien USD 11.62B 1.68B Jun/2026
Philips EUR 7.42B 8M Jun/2026
PPG Industries USD 5.23B 276M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 31.93B 1.92B Jun/2026
SAP EUR 19.11B 624M Sep/2026
Solvay EUR 1.78B 6M Jun/2026
UCB EUR 4.4B 470M Dec/2025
Umicore EUR 4.55B 293.7M Jun/2026
Vinci EUR 59.23B 1.14B Jun/2026